Lecture+7+-++G+Williams
description
Transcript of Lecture+7+-++G+Williams
-
TOPRA Strategic Planning in Regulatory Affairs
Electronic Submissions
Strategic Implications
ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSIONENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSIONENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION
A presentation by Dr. Geoffrey Williams, Director, Regulatory Operations, Daiichi Sankyo Development Ltd.
1
-
At the end of this session the attendee should be able to:
Describe the key benefits and challenges for adopting electronic submissions in the pharma industry
Describe the key components and differences between the two commonest electronic submission formats: the eCTD and NeeS formats
Learning Outcomes
NeeS formats
Understand the key challenges in developing a global electronic submissions strategy
Describe the acceptability of the eCTD and electronic submissions in the key global markets
2
-
What is an electronic submission?
What are the benefits and challenges to working with electronic submissions
What are the features and components of the main formats?
What are the key considerations in developing a global electronic submission strategy?
In this presentation we will cover
electronic submission strategy?
What is the current status of electronic submission acceptance around the world?
Whats next in the electronic submission world?
Some conclusions
3
-
Some files?
A copy of an MS Word file of a labelling document
A PDF of a study report
A set of scanned images in a zip file
What is an electronic submission?
A set of scanned images in a zip file
A set of PDF files with a linked Table of Contents
A full submission meeting the eCTD specification
4
-
A submission format?
Files on a CD or DVD
Files attached to an e-mail
Files submitted via Eudralink
What is an electronic submission?
Files submitted via CESP
Files submitted via a Gateway
5
-
A reduction/elimination of paper
Ease of navigation
An electronic Table of Contents (TOC)
Bookmarks
Hyperlinks
What are the benefits of an electronic submission?
Hyperlinks
Easy to search or query
Searching for documents
Searching the content of the documents (full text search)
Easy to copy information
A means to relate the information in this dossier to other submitted information
A means to relate this dossier to other dossiers6
-
Standards for the documents
Standards for the dossiers
The structure of the dossier
Technical validation of the submissions
What are the challenges of electronic submissions?
Technical validation of the submissions
The need for tools to be able to create and manage the submissions
A technical understanding of the tools and formats
For when things go wrong
7
-
Basic standards for electronic documents are included in the eCTD specification
Create documents from an electronic source and convert this directly to PDF
Create templates for your documents to standardise and control the content of the documents
Document Standards
and control the content of the documents
This also makes conversion to PDF easier
Avoid scanning paper and dont get caught up in trying to create searchable text (OCR)
Train your writers to use MS Word properly!
Most people have never been on a course about their main authoring tool
8
-
The electronic Common Technical Document (eCTD) and the Non-eCTDeSubmission (NeeS) format are two of the more widely used formats
The following slides provide more
Dossier standards: eCTD and NeeS
The following slides provide more detail about these submission formats
9
-
The eCTD is a specification for an electronic submission created by the ICH
The concept of a common global electronic submission format was an early topic for the ICH
Unfortunately, there was no global submission format, so the electronic submission topic had to wait for the CTD to be
The eCTD
electronic submission topic had to wait for the CTD to be developed
The intention is to give a common format for the electronic version of the CTD dossier
This means it has to accommodate all of the features of the CTD
The common dossier structure provided by the CTD
AND
The regional content requirements
ICH have defined the common part but each region/country must also define their pieces as well 10
-
One of the key features of the eCTD is Lifecycle Management
This is providing information about the relationship of one document to another
Represented by the operation attribute
eCTD Lifecycle Management
Represented by the operation attribute
new, replace, delete and append
And the modified file attribute
And also providing information about the relationship of one submission to another
Represented by related sequence attribute in the envelope
11
-
Leaf Documents
The files with the information
Mostly PDF files
Some data files, where required (mainly USA)
A Directory Structure
Somewhere to put all of the files
Main components of the eCTD
Somewhere to put all of the files
The XML Backbone
A way of managing all of the information about the submission and the files in the submission, as well as the relationships to previously submitted files and submissions
A Style sheet
A simple way to view the information in thesubmission
12
Agency Review Tools
The review environment forthe agency, displaying thelifecycle management info
Provides Supports
-
The eCTD folder structure
13
-
eCTD leaf files
14
-
The eCTD XML backbone
15
-
The NeeS format was developed in Europe and was intended as a stepping stone to the eCTD
Use the same files and folders as the eCTD but simplify the navigation by using a PDF TOC with hyperlinks
The NeeS submission format
with hyperlinks
What is not available is the lifecycle management information
But note that the NeeS format is still a good standard!
NeeS has also become a term used in many regions16
-
Leaf Documents
The files with the information
Mostly PDF files
Some data files, where required (mainly USA)
A Directory Structure
Somewhere to put all of the files
Main components of a NeeSsubmission
XXXXXXXXXXXXXXXXXXXXXXXXXXXX
Somewhere to put all of the files
The XML Backbone
A way of managing all of the information about the submission and the files in the submission, as well as the relationships to previously submitted files and submissions
A Style sheet
A simple way to view the information in thesubmission
17
Agency Review Tools
The review environment forthe agency, displaying thelifecycle management info
Provides Supports
-
Leaf Documents
The files with the information
Mostly PDF files
[Using the eCTD standards and file naming]
A Directory Structure
Somewhere to put all of the files
Main components of a NeeSsubmission
Somewhere to put all of the files
[The same structure as the eCTD]
A PDF Table of Contents
A way to navigate the structure to the individual content files
18
-
Accept that you are going to work electronically, so make the changes to your processes and standards to gain the most benefit from the format
Invest in the tools (document management,
Developing a global electronic submission strategy (1)
Invest in the tools (document management, submission publishing tools and ancillary tools)
Implement the standards for the documents and get the authors in the functions to own them
Prepare to implement the CTD for all of your old products (and think baseline)
Fully adopt the eCTD as the starting point for all of your submissions in all regions
19
-
Your objective will be to author and publish the scientific and regulatory content only once
But do so in a way that maximises the way it can be reused
You will want to create content in an electronic submission ready state
eSub ready content con usually be printed out easily, but its not easy to
Developing a global electronic submission strategy (2)
eSub ready content con usually be printed out easily, but its not easy to take paper and include it in an electronic submission
You will want to develop the product (submission) strategy in a way that maximises the ability to reuse content
Write content so it can be reused in all regions
Look for ways to reuse one submission in another region (e.g. EU to Switzerland, EU to Australia, etc.)
20
-
These are the standards used most widely
ICH regions and more widely
The standards are a higher/highest common denominator so the lower standards can usually be easily created from the documents
Why adopt the CTD/eCTD?
usually be easily created from the documents and submissions
For example, the NeeS is a simplified eCTD, so if you can create an eCTD you can create a NeeS
Even creating some of the other standards are easier if you start with the CTD/eCTD (e.g. the ASEAN CTD)
21
-
Having made the investment, use the document and submission standards whenever you can
The standards for an electronic document make sense whether there is a Marketing Application immediately planned or not
Bad electronic documents are more difficult to use than bad
Standards where there are none (published)
Bad electronic documents are more difficult to use than bad paper!
And it is extra effort to upgrade the documents later
Extrapolate from the eCTD and NeeS standards when you are creating other submission types where there might not be a published standard
CTAs in Europe and the rest of the world
Submissions for Scientific Advice, Paediatrics or Orphan Drug Designation
22
-
I will talk about the documented acceptability of electronic submissions around the world
However, most agency reviewers are now used to working electronically
Even if their regulations say the submission
Use electronic submissions whenever you can
Even if their regulations say the submission must be in paper, you can bet that they will create their assessment report in MS Word and e-mail it to you when they are done
Therefore, always put the electronic submission into the package for the agency, most reviewers will use it in preference to the paper
23
-
A good electronic submission and well authored documents are a valuable resource to your company
Well managed documents will help your own internal business
Make your internal use part of the strategy
your own internal business
Combine these benefits in to your strategy and ensure that your company gets the most from the investment in working electronically
24
-
The maximum reuse of content is only possible when the product strategy is a global one
There may be good reasons for regional differences
Different regional guidance for the disease
Business decisions on partnering and licensing
Caveat 1: Do you have a global product strategy?
Business decisions on sourcing and manufacture
But try and avoid internal issues leading to regionally different content
Aim to write global overviews and summaries
Publish documents in a way that allows global reuse (particularly CSRs)
25
-
The strategy points I have discussed work best for the first submission of the initial Marketing Authorisation in each of the countries
This is the one time you can control the content and choose to keep it as harmonised as possible
Thereafter the review processes and timelines, the
Caveat 2: Product lifecycle grows differently in each region
Thereafter the review processes and timelines, the preferences and foibles of each reviewing agency and the internal priorities will take over
However, continue to look for the opportunities to create and reuse common content
26
-
The US FDA were the earliest adopters of the concept of electronic submissions, both informally and then more formally
The additional data requirements have made the use of electronic submissions a necessity
Electronic submissions: Region by region The United States (1)
The eCTD has been a requirement since 2007
Thankfully, the slight differences between small molecule and biologics submissions have been removed
But the NDA presubmission process can still lead to some individual requests and inclusions
27
-
The biggest difference is the handling of the data
Submissions require copies of CRFS and datasets from the outset
Dont forget the Nonclinical datasets
Other additions (adjudication packages, Medwatchforms, etc.) may be requested
Electronic submissions: Region by region The United States (2)
forms, etc.) may be requested
The Nonclinical and Clinical reports must also be submitted with a Study Tagging File (STF)
The STF is a mini XML backbone to manage the components of each report
The Clinical tagging is defined in terms of the ICH E3 sections, so it is easier if your templates use these sections
28
-
The eCTD is also used in the IND phase
There is good business case for getting the benefit of the lifecycle management capabilities of the eCTD in the IND
The FDA already allows for direct cross referencing from the NDA eCTD back to content first submitted as part of the IND
Electronic submissions: Region by region The United States (3)
content first submitted as part of the IND
29
-
Electronic submissions are made through the FDA Electronic Submission Gateway (ESG) making for a fully electronic process
Many of the largest initial NDA submissions will need to be submitted on hard media
Electronic submissions: Region by region The United States (4)
30
-
The EU review processes and the autonomy of the individual EU Member States makes this a more complex environment to work in
However, the situation is a lot clearer now than it was just two or three years ago
Electronic submissions: Region by region EU (1)
In addition, if you aim to optimise your investment in eCTD and use this format whenever you can then the number of issues are very much reduced
31
-
The Centralised Procedure
The eCTD has been the only acceptable format for the last four years
Since March 2014 the use of the EMA Gateway has also been mandated
The EMA has invested in providing the tools to review the eCTD
Electronic submissions: Region by region EU (2)
The EMA has invested in providing the tools to review the eCTDto all EU NCAs
Submission to the CHMP members in the NCAs is also getting easier
Over one third of the NCAs will collect their copy of the submission from the Central Repository
Over one third of NCAs will accept their eCTD via CESP
Leaving less than one third who still require copies on CD/DVD
32
-
The Mutual Recognition and Decentralised Procedures
These procedures (and the NP) are more subject to the individual whims of the NCAs
However, the eCTD is acceptable at all EU NCAs, in large part to the experience gained from participating in the CP
Electronic submissions: Region by region EU (3)
part to the experience gained from participating in the CP
There is specific guidance on how to use the eCTD in these procedures
There is move to make the eCTD mandatory for both procedures by the end of 1Q2018 (with all new MAAs in DCP 3Q2015 and MRP 1Q2017)
33
-
eSubmission Roadmap
(reflecting final adopted version 1.0 dated 7th Nov 2014)
Use of VNeeS in CP, DCP and MRP (vet)
All submissions in CP,
DCP and MRP (human) in
eCTD
Ongoing/optional
Mandatory
Use of eCTD v.4
All submissions in CP, DCP and MRP (vet) in VNeeS
Use of NeeS and eCTD in DCP and MRP (human)New MAA in DCP (human) in eCTD
All submissions in MRP (human)
New MAA in DCP and MRP
(human) in eCTD
All other in CP and all
MRP submissions (vet)
New MAA in CP and DCP
(vet) in VNeeS
All other MRP submissions
(human)
All submissions in CP (human) in eCTD
draft
eSub
Roadmap
NCA &
industry
survey
eSub
Roadmap
Adoption
eSubmission Roadmap Timelines
2013 2014 2015 2016 2017 2018
Use of eAF in all procedures (human and vet)
Single Submission Portal
with integration of eAF
for all submissions
(human and vet)
CESP (human and vet)
eGateway (CP)
(human and vet)eGateway (CP, human)
NCA use of Common Repository for all CP submissions
(human)
NCA use of Common Repository for CP submissions
(human)
Single submission portal - combined CESP/Gatewayin all other procedures (human and vet)
in CPeAF in all procedures (human and vet)
Use of PSUR Repository for all CAPs and NAPs
(human)
Use of PSUR Repository for CAPs
and NAPs (human)
Single submission portal - combined CESP/Gatewayin CP (human)
in all other procedures
-
National Procedures
The greatest challenge will come with products registered via the National Procedures
These are generally old cash cow products that rely on a minimal investment to maintain on the market
This has often meant only converting content to the CTD when
Electronic submissions: Region by region EU (3)
This has often meant only converting content to the CTD when absolutely necessary, let alone the eCTD
Often these projects ae maintained on a national basis so the investment for electronic submission tools may need to be made outside the central R&D groups
They have been a prime candidate for the NeeS format, rather than the eCTD because of the lower technical requirement
Note that the EU eSubmission Roadmap is silent on the subject of mandatory eCTD in NP, but expect that it will come along at some point
35
-
Means of submission for MRP and DCP
The CESP portal is acceptable as a submission route in 26 EU countries and has been a success in providing a simple way to submit electronically to EU NCAs
Some countries still have other requirements but the message is generally that electronic working is the way to go
Electronic submissions: Region by region EU (4)
Other submissions
The new CT regulation is likely to make an eCTA specification much more of a reality
However, assume that it will use standards for documents already in the eCTD
Many NCAs are looking at other submission processes and starting to introduce electronic requirements (PSURs, Scientific Advice, etc.)
36
-
Marketing Applications
As ICH members, the PMDA have been adopters of the eCTD, though at a slower pace than US and EU
The eCTD is not adopted for all submission types
Not used for generics and many CMC submission types
Electronic submissions: Region by region Japan (1)
The eCTD lifecycle is not implemented in the same way
However, the eCTD is moving from an archive format to a standard submission format without paper
37
-
Canada
Health Canada have been members of the ICH eCTDExpert Working Group since the start
eCTDs have been acceptable since 2009 for Marketing Applications (NDS)
Electronic submissions: Region by region Other Regions (1)
Not acceptable for clinical trial submissions
Switzerland
Also founder members of the ICH eCTD EWG
SwissMedic will only accept the eCTD (there is no equivalent to the NeeS)
However, the Swiss guidance follows the EU in many places and allow for the easy creation of the initial MAA submission
38
-
Australia
The TGA have recently joined the ICH eCTD EWG to support their eCTD implementation project
There is currently a pilot running for companies to submit eCTDs
Certain categories of MA submissions only
Due to finish in Feb 2015, but likely to accept eCTDs upon
Electronic submissions: Region by region Other Regions (2)
Due to finish in Feb 2015, but likely to accept eCTDs upon request
Removes the need to produce vast amounts of paper
Saudi Arabia
The SFDA is very active at the moment in implementing the eCTD
Not without issues (e.g. the need for baselines for all products)
Not yet clear how this affects other GCC states, though UAE, Oman and Bahrain have shown interest as well 39
-
South Africa
The MCC have also been running a pilot with the eCTD
The plans for further adoption are not so clear
Thailand
The Thai FDA have also been running an eCTD pilot
Electronic submissions: Region by region Other Regions (3)
The Thai FDA have also been running an eCTD pilot
Turkey
Turkey have talked about a NeeS for eCTD, but using folders named in Turkish
Making all the links in all of the files we created for the eCTDinvalid
40
-
The ASEAN Countries
Annoyingly, the ASEAN countries decided not to adopt the ICH CTD, despite being associate members of ICH through the ICH Global Cooperation Group
The ASEAN CTD basically follows the ICH CTD structure, but they renumbered it into 4 modules
Electronic submissions: Region by region Other Regions (4)
The ASEAN countries have also pushed the use of the ASEAN CTD over the ICH CTD
There is also now talk of them producing an ASEAN eCTD based on the ASEAN CTD
However, the use of the basic ICH CTD structure means it is an administrative change to the documents, rather than anything more complicated
41
-
Other Countries
Many other countries will accept CTD format submissions, including the following agencies
Hong Kong, Singapore, China, Taiwan, Mexico, Brazil, Argentina
Many other countries accept electronic filings based on
Electronic submissions: Region by region Other Regions (5)
Many other countries accept electronic filings based on their local requirements (NeeS like submissions)
Russia, Turkey, Egypt, India, Israel, Malaysia, South Korea, Mexico, Venezuela, Bosnia Hercegovinia
All of this means that if we work from the high level standards of the eCTD we can work back to the standards acceptable in these countries, and most reviewers would probably like to receive an electronic submission
42
-
The ICH have been working on eCTD v4.0 for over 5 years
The development is a collaboration with ISO and HL7 which should lead to a technical standard that is also an internationally recognised standard
This offers many more possibilities to see the eCTD adopted by agencies
Whats next? (1)
eCTD v4.0 is intended to address a number of business scenarios where the current eCTD specifcation (v3.2.2) struggles
Particularly some of the more complex EU procedures for Grouping and Worksharing in the MRP/DCP
Also more flexibility in extending the standard to other non-CTD submission structures
The initial signoff is due in late 2015 with implementation activities beginning in 2016
43
-
We should expect to see the electronic transmission of data increase with more portals and gateways
The content of the dossier will become more structured with standards introduced for the data
Electronic Application Forms to improve the uploading and processing of submissions
Whats next? (2)
Structured content to drive compliance for documents like labelling (e.g. SPL in the US)
Eventually, we may see two way communication between applicant and regulator, with the flow in both directions fitting together to show relationships and approval status
44
-
The acceptance of electronic submissions has been increasing rapidly over the past two or three years
The rapidly increasing document and data requirements of regulatory agencies for the content of their dossiers is a significant driver for this change
This is no longer something that only matters in the
Conclusions
This is no longer something that only matters in the ICH regions, some of the keenest adopters are in the growing markets who see technology as a way to challenge and keep up with the bigger agencies
Industry needs to accept this change and embrace it
The key is making the management of electronic documents and submissions a key part of our internal information management strategy (eSubs are no longer just something we create for regulators)
45
-
We are still a long way from having a single format that is acceptable across the whole world (if this was ever a real possibility)
However, the willingness of the regulators to accept electronic ways of working allows industry to develop more coherent strategies for electronic submissions
Conclusions
Look to move to the highest specification you can support as this will be most flexible in meeting the needs across all countries, and also sets you up for the future
46
-
What is an electronic submission?
What are the benefits and challenges to working with electronic submissions
What are the features and components of the main formats?
What are the key considerations in developing a global
In this presentation we covered
What are the key considerations in developing a global electronic submission strategy?
What is the current status of electronic submission acceptance around the world?
Whats next in the electronic submission world?
Some conclusions
47
-
ICH
http://www.ich.org/products/electronic-standards.html
US
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/ucm153574.htm
Recommended references
3574.htm
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/UCM085361
Europe
http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000116.jsp&mid=WC0b01ac0580028c2b
http://esubmission.ema.europa.eu/index.htm
48
-
Canada
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/ectd/index-eng.php
Switzerland
https://www.swissmedic.ch/zulassungen/01520/01662/index.html?lang=en
Recommended references
ex.html?lang=en
Other Regions Australia
http://www.tga.gov.au/australian-ectd-submissions
Other Regions Saudi Arabia
http://www.sfda.gov.sa/en/drug/drug_reg/Pages/drug_reg.aspx?catid=2
49
-
Other Regions South Africa
http://www.mccza.com/dynamism/default_dynamic.asp?grpID=30&doc=dynamic_generated_page.asp&categID=178&groupID=30#A focus on ZA CTD
Other Regions Thailand
http://drug.fda.moph.go.th/eng/e_submiss.asp
Recommended references
http://drug.fda.moph.go.th/eng/e_submiss.asp
ASEAN CTD Specification
http://www.hsa.gov.sg/content/dam/HSA/HPRG/Western_Medicine/Overview_Framework_Policies/Guidelines_on_Drug_Registration/ACTD_OrganizationofDossier.pdf
50
-
QUESTIONS?
51
-
Acknowledgements
The EFPIA members of the ICH M8 EWG
The members of the EFPIA eCTD Topic Group
Contact details
Name: Geoff Williams
Email: [email protected]
52